nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—ALDH1A1—breast cancer	0.189	0.451	CbGaD
Tretinoin—RXRB—breast cancer	0.114	0.273	CbGaD
Tretinoin—RARB—breast cancer	0.0792	0.189	CbGaD
Tretinoin—CYP2A6—Letrozole—breast cancer	0.0307	0.108	CbGbCtD
Tretinoin—CYP1A1—breast cancer	0.0222	0.0531	CbGaD
Tretinoin—CYP1A1—Toremifene—breast cancer	0.0214	0.0753	CbGbCtD
Tretinoin—CYP3A4—breast cancer	0.0142	0.0339	CbGaD
Tretinoin—CYP2B6—Thiotepa—breast cancer	0.0135	0.0476	CbGbCtD
Tretinoin—CYP2C9—Anastrozole—breast cancer	0.00942	0.0331	CbGbCtD
Tretinoin—CYP3A5—Lapatinib—breast cancer	0.00938	0.033	CbGbCtD
Tretinoin—CYP2A6—Tamoxifen—breast cancer	0.00916	0.0322	CbGbCtD
Tretinoin—CYP2B6—Raloxifene—breast cancer	0.00902	0.0317	CbGbCtD
Tretinoin—CYP2C8—Lapatinib—breast cancer	0.00902	0.0317	CbGbCtD
Tretinoin—CYP1A1—Tamoxifen—breast cancer	0.00782	0.0275	CbGbCtD
Tretinoin—CYP3A4—Exemestane—breast cancer	0.00723	0.0254	CbGbCtD
Tretinoin—CYP2C9—Idarubicin—breast cancer	0.00714	0.0251	CbGbCtD
Tretinoin—CYP2C8—Raloxifene—breast cancer	0.00683	0.024	CbGbCtD
Tretinoin—CYP2A6—Fluorouracil—breast cancer	0.00675	0.0237	CbGbCtD
Tretinoin—CYP3A7—Tamoxifen—breast cancer	0.00626	0.022	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Tamoxifen—breast cancer	0.00626	0.022	CbGbCtD
Tretinoin—CYP3A4—Letrozole—breast cancer	0.00615	0.0216	CbGbCtD
Tretinoin—CYP2B6—Tamoxifen—breast cancer	0.00596	0.021	CbGbCtD
Tretinoin—CYP3A4—Anastrozole—breast cancer	0.00548	0.0193	CbGbCtD
Tretinoin—CYP3A4—Toremifene—breast cancer	0.00501	0.0176	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Paclitaxel—breast cancer	0.00487	0.0171	CbGbCtD
Tretinoin—CYP3A7—Paclitaxel—breast cancer	0.00487	0.0171	CbGbCtD
Tretinoin—CYP3A7—Irinotecan—breast cancer	0.00481	0.0169	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Irinotecan—breast cancer	0.00481	0.0169	CbGbCtD
Tretinoin—CYP3A5—Tamoxifen—breast cancer	0.0047	0.0165	CbGbCtD
Tretinoin—CYP3A4—Fulvestrant—breast cancer	0.00466	0.0164	CbGbCtD
Tretinoin—CYP2B6—Irinotecan—breast cancer	0.00458	0.0161	CbGbCtD
Tretinoin—CYP2C8—Tamoxifen—breast cancer	0.00451	0.0159	CbGbCtD
Tretinoin—CYP3A4—Thiotepa—breast cancer	0.00415	0.0146	CbGbCtD
Tretinoin—CYP2C9—Capecitabine—breast cancer	0.00391	0.0138	CbGbCtD
Tretinoin—CYP3A4—Ixabepilone—breast cancer	0.0038	0.0134	CbGbCtD
Tretinoin—CYP3A4—Lapatinib—breast cancer	0.00366	0.0129	CbGbCtD
Tretinoin—CYP3A5—Paclitaxel—breast cancer	0.00365	0.0129	CbGbCtD
Tretinoin—CYP3A5—Irinotecan—breast cancer	0.00361	0.0127	CbGbCtD
Tretinoin—CYP3A7—Docetaxel—breast cancer	0.00352	0.0124	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Docetaxel—breast cancer	0.00352	0.0124	CbGbCtD
Tretinoin—CYP2C8—Paclitaxel—breast cancer	0.00351	0.0124	CbGbCtD
Tretinoin—CYP2C8—Fluorouracil—breast cancer	0.00333	0.0117	CbGbCtD
Tretinoin—CYP2C9—Tamoxifen—breast cancer	0.00315	0.0111	CbGbCtD
Tretinoin—CYP3A4—Raloxifene—breast cancer	0.00277	0.00975	CbGbCtD
Tretinoin—CYP3A5—Docetaxel—breast cancer	0.00264	0.00929	CbGbCtD
Tretinoin—CYP2B6—Doxorubicin—breast cancer	0.0025	0.00879	CbGbCtD
Tretinoin—CYP2C9—Paclitaxel—breast cancer	0.00245	0.00862	CbGbCtD
Tretinoin—CYP2C9—Fluorouracil—breast cancer	0.00232	0.00816	CbGbCtD
Tretinoin—CYP3A4—Vinorelbine—breast cancer	0.00203	0.00713	CbGbCtD
Tretinoin—CYP3A4—Tamoxifen—breast cancer	0.00183	0.00644	CbGbCtD
Tretinoin—CYP3A4—Mitoxantrone—breast cancer	0.00179	0.00628	CbGbCtD
Tretinoin—RARRES1—mammary gland—breast cancer	0.00161	0.0317	CbGeAlD
Tretinoin—CYP3A4—Paclitaxel—breast cancer	0.00143	0.00501	CbGbCtD
Tretinoin—CYP3A4—Irinotecan—breast cancer	0.00141	0.00494	CbGbCtD
Tretinoin—RARRES1—nipple—breast cancer	0.00133	0.0262	CbGeAlD
Tretinoin—GPRC5A—female reproductive system—breast cancer	0.00132	0.0259	CbGeAlD
Tretinoin—CYP3A4—Vinblastine—breast cancer	0.00125	0.0044	CbGbCtD
Tretinoin—CYP3A4—Docetaxel—breast cancer	0.00103	0.00362	CbGbCtD
Tretinoin—CRABP1—nipple—breast cancer	0.000985	0.0194	CbGeAlD
Tretinoin—ALDH1A1—mammary gland—breast cancer	0.000897	0.0177	CbGeAlD
Tretinoin—CRABP2—nipple—breast cancer	0.000891	0.0176	CbGeAlD
Tretinoin—RARRES1—skin of body—breast cancer	0.000852	0.0168	CbGeAlD
Tretinoin—ALDH1A2—embryo—breast cancer	0.000842	0.0166	CbGeAlD
Tretinoin—CRABP1—embryo—breast cancer	0.000813	0.016	CbGeAlD
Tretinoin—RARRES1—endometrium—breast cancer	0.000803	0.0158	CbGeAlD
Tretinoin—CYP3A4—Doxorubicin—breast cancer	0.000768	0.0027	CbGbCtD
Tretinoin—ALDH1A1—nipple—breast cancer	0.000742	0.0146	CbGeAlD
Tretinoin—RARRES1—uterus—breast cancer	0.00074	0.0146	CbGeAlD
Tretinoin—RARA—mammary gland—breast cancer	0.000738	0.0146	CbGeAlD
Tretinoin—CRABP2—embryo—breast cancer	0.000735	0.0145	CbGeAlD
Tretinoin—RARRES1—pituitary gland—breast cancer	0.000727	0.0143	CbGeAlD
Tretinoin—RARRES1—adipose tissue—breast cancer	0.000724	0.0143	CbGeAlD
Tretinoin—ALDH1A1—Vinblastine—Vinorelbine—breast cancer	0.000707	0.462	CbGdCrCtD
Tretinoin—RARRES1—female reproductive system—breast cancer	0.000665	0.0131	CbGeAlD
Tretinoin—Isotretinoin—RXRB—breast cancer	0.000653	0.173	CrCbGaD
Tretinoin—RARG—nipple—breast cancer	0.00065	0.0128	CbGeAlD
Tretinoin—RARRES1—adrenal gland—breast cancer	0.000649	0.0128	CbGeAlD
Tretinoin—Vitamin A—ALDH1A1—breast cancer	0.000641	0.17	CrCbGaD
Tretinoin—CRABP1—skin of body—breast cancer	0.000631	0.0124	CbGeAlD
Tretinoin—NR0B1—pituitary gland—breast cancer	0.000626	0.0123	CbGeAlD
Tretinoin—ALDH1A2—endometrium—breast cancer	0.000616	0.0121	CbGeAlD
Tretinoin—ALDH1A1—embryo—breast cancer	0.000612	0.0121	CbGeAlD
Tretinoin—RARRES1—female gonad—breast cancer	0.000605	0.0119	CbGeAlD
Tretinoin—NR0B1—female reproductive system—breast cancer	0.000573	0.0113	CbGeAlD
Tretinoin—CRABP2—skin of body—breast cancer	0.00057	0.0112	CbGeAlD
Tretinoin—ALDH1A2—uterus—breast cancer	0.000568	0.0112	CbGeAlD
Tretinoin—NR0B1—adrenal gland—breast cancer	0.000559	0.011	CbGeAlD
Tretinoin—ALDH1A2—pituitary gland—breast cancer	0.000558	0.011	CbGeAlD
Tretinoin—ALDH1A2—adipose tissue—breast cancer	0.000555	0.0109	CbGeAlD
Tretinoin—Acitretin—RXRB—breast cancer	0.000555	0.147	CrCbGaD
Tretinoin—CRABP1—pituitary gland—breast cancer	0.000538	0.0106	CbGeAlD
Tretinoin—CRABP2—endometrium—breast cancer	0.000538	0.0106	CbGeAlD
Tretinoin—Alitretinoin—RXRB—breast cancer	0.000532	0.141	CrCbGaD
Tretinoin—NR0B1—female gonad—breast cancer	0.000521	0.0103	CbGeAlD
Tretinoin—ALDH1A2—female reproductive system—breast cancer	0.000511	0.0101	CbGeAlD
Tretinoin—ALDH1A2—adrenal gland—breast cancer	0.000498	0.00982	CbGeAlD
Tretinoin—CRABP1—female reproductive system—breast cancer	0.000493	0.00971	CbGeAlD
Tretinoin—CRABP2—pituitary gland—breast cancer	0.000487	0.00959	CbGeAlD
Tretinoin—NR0B1—endocrine gland—breast cancer	0.000485	0.00955	CbGeAlD
Tretinoin—CRABP2—adipose tissue—breast cancer	0.000485	0.00955	CbGeAlD
Tretinoin—ALDH1A1—skin of body—breast cancer	0.000475	0.00937	CbGeAlD
Tretinoin—ALDH1A2—female gonad—breast cancer	0.000465	0.00916	CbGeAlD
Tretinoin—Isotretinoin—RARB—breast cancer	0.000453	0.12	CrCbGaD
Tretinoin—ALDH1A1—endometrium—breast cancer	0.000448	0.00883	CbGeAlD
Tretinoin—CRABP2—female reproductive system—breast cancer	0.000445	0.00878	CbGeAlD
Tretinoin—RXRA—female reproductive system—breast cancer	0.000443	0.00874	CbGeAlD
Tretinoin—CRABP2—adrenal gland—breast cancer	0.000435	0.00857	CbGeAlD
Tretinoin—ALDH1A2—endocrine gland—breast cancer	0.000432	0.00852	CbGeAlD
Tretinoin—ALDH1A1—Idarubicin—Epirubicin—breast cancer	0.000428	0.28	CbGdCrCtD
Tretinoin—RXRG—pituitary gland—breast cancer	0.000425	0.00838	CbGeAlD
Tretinoin—RXRG—adipose tissue—breast cancer	0.000424	0.00835	CbGeAlD
Tretinoin—CRABP1—endocrine gland—breast cancer	0.000417	0.00822	CbGeAlD
Tretinoin—CYP4A11—endocrine gland—breast cancer	0.000417	0.00822	CbGeAlD
Tretinoin—RARG—skin of body—breast cancer	0.000416	0.0082	CbGeAlD
Tretinoin—ALDH1A1—uterus—breast cancer	0.000413	0.00814	CbGeAlD
Tretinoin—ALDH1A1—pituitary gland—breast cancer	0.000405	0.00799	CbGeAlD
Tretinoin—CRABP2—female gonad—breast cancer	0.000405	0.00799	CbGeAlD
Tretinoin—ALDH1A1—adipose tissue—breast cancer	0.000404	0.00796	CbGeAlD
Tretinoin—RXRA—female gonad—breast cancer	0.000404	0.00795	CbGeAlD
Tretinoin—RARB—female reproductive system—breast cancer	0.000398	0.00785	CbGeAlD
Tretinoin—ALDH1A1—Idarubicin—Doxorubicin—breast cancer	0.000396	0.259	CbGdCrCtD
Tretinoin—RARRES1—lymph node—breast cancer	0.000389	0.00767	CbGeAlD
Tretinoin—RARB—adrenal gland—breast cancer	0.000389	0.00766	CbGeAlD
Tretinoin—Acitretin—RARB—breast cancer	0.000385	0.102	CrCbGaD
Tretinoin—RXRG—adrenal gland—breast cancer	0.00038	0.00749	CbGeAlD
Tretinoin—CRABP2—endocrine gland—breast cancer	0.000377	0.00743	CbGeAlD
Tretinoin—RXRA—endocrine gland—breast cancer	0.000375	0.0074	CbGeAlD
Tretinoin—ALDH1A1—female reproductive system—breast cancer	0.000371	0.00732	CbGeAlD
Tretinoin—Alitretinoin—RARB—breast cancer	0.000369	0.0976	CrCbGaD
Tretinoin—RARA—endometrium—breast cancer	0.000369	0.00727	CbGeAlD
Tretinoin—RARB—female gonad—breast cancer	0.000362	0.00714	CbGeAlD
Tretinoin—ALDH1A1—adrenal gland—breast cancer	0.000362	0.00714	CbGeAlD
Tretinoin—RARG—uterus—breast cancer	0.000361	0.00713	CbGeAlD
Tretinoin—RXRB—adrenal gland—breast cancer	0.000357	0.00704	CbGeAlD
Tretinoin—RARG—adipose tissue—breast cancer	0.000354	0.00697	CbGeAlD
Tretinoin—ALDH1A1—bone marrow—breast cancer	0.00035	0.00691	CbGeAlD
Tretinoin—RARA—uterus—breast cancer	0.00034	0.0067	CbGeAlD
Tretinoin—ALDH1A1—female gonad—breast cancer	0.000338	0.00666	CbGeAlD
Tretinoin—RARB—endocrine gland—breast cancer	0.000337	0.00664	CbGeAlD
Tretinoin—RARA—pituitary gland—breast cancer	0.000334	0.00658	CbGeAlD
Tretinoin—RXRB—female gonad—breast cancer	0.000333	0.00657	CbGeAlD
Tretinoin—RARA—adipose tissue—breast cancer	0.000332	0.00655	CbGeAlD
Tretinoin—RXRG—endocrine gland—breast cancer	0.000329	0.00649	CbGeAlD
Tretinoin—RARG—female reproductive system—breast cancer	0.000325	0.00641	CbGeAlD
Tretinoin—RARG—adrenal gland—breast cancer	0.000317	0.00625	CbGeAlD
Tretinoin—ALDH1A1—endocrine gland—breast cancer	0.000314	0.00619	CbGeAlD
Tretinoin—RXRB—endocrine gland—breast cancer	0.00031	0.00611	CbGeAlD
Tretinoin—RARA—female reproductive system—breast cancer	0.000306	0.00602	CbGeAlD
Tretinoin—ALDH1A2—lymph node—breast cancer	0.000299	0.00589	CbGeAlD
Tretinoin—RARA—adrenal gland—breast cancer	0.000298	0.00588	CbGeAlD
Tretinoin—RARG—female gonad—breast cancer	0.000296	0.00583	CbGeAlD
Tretinoin—CYP2C8—mammary gland—breast cancer	0.000293	0.00577	CbGeAlD
Tretinoin—RARA—bone marrow—breast cancer	0.000288	0.00569	CbGeAlD
Tretinoin—RARA—female gonad—breast cancer	0.000278	0.00548	CbGeAlD
Tretinoin—CYP2C18—endocrine gland—breast cancer	0.000276	0.00544	CbGeAlD
Tretinoin—CYP3A7—endocrine gland—breast cancer	0.000263	0.00518	CbGeAlD
Tretinoin—CYP2C9—mammary gland—breast cancer	0.00026	0.00512	CbGeAlD
Tretinoin—RARA—endocrine gland—breast cancer	0.000259	0.0051	CbGeAlD
Tretinoin—CYP2A6—adipose tissue—breast cancer	0.000235	0.00462	CbGeAlD
Tretinoin—RARB—lymph node—breast cancer	0.000233	0.00459	CbGeAlD
Tretinoin—CYP1A1—nipple—breast cancer	0.000223	0.0044	CbGeAlD
Tretinoin—ALDH1A1—lymph node—breast cancer	0.000217	0.00428	CbGeAlD
Tretinoin—RARG—lymph node—breast cancer	0.00019	0.00375	CbGeAlD
Tretinoin—RARA—lymph node—breast cancer	0.000179	0.00352	CbGeAlD
Tretinoin—CYP1A1—epithelium—breast cancer	0.00015	0.00296	CbGeAlD
Tretinoin—CYP2C8—endometrium—breast cancer	0.000146	0.00288	CbGeAlD
Tretinoin—CYP1A1—skin of body—breast cancer	0.000143	0.00282	CbGeAlD
Tretinoin—CYP2B6—skin of body—breast cancer	0.000139	0.00274	CbGeAlD
Tretinoin—CYP2C8—pituitary gland—breast cancer	0.000132	0.00261	CbGeAlD
Tretinoin—CYP1A1—uterus—breast cancer	0.000124	0.00245	CbGeAlD
Tretinoin—CYP1A1—adipose tissue—breast cancer	0.000122	0.0024	CbGeAlD
Tretinoin—CYP2C8—female reproductive system—breast cancer	0.000121	0.00239	CbGeAlD
Tretinoin—CYP3A5—adipose tissue—breast cancer	0.000119	0.00234	CbGeAlD
Tretinoin—CYP1A1—female reproductive system—breast cancer	0.000112	0.0022	CbGeAlD
Tretinoin—CYP2B6—female reproductive system—breast cancer	0.000109	0.00214	CbGeAlD
Tretinoin—CYP2C9—female reproductive system—breast cancer	0.000108	0.00212	CbGeAlD
Tretinoin—CYP2B6—adrenal gland—breast cancer	0.000106	0.00209	CbGeAlD
Tretinoin—CYP2C8—endocrine gland—breast cancer	0.000102	0.00202	CbGeAlD
Tretinoin—CYP1A1—female gonad—breast cancer	0.000102	0.002	CbGeAlD
Tretinoin—CYP3A5—female gonad—breast cancer	9.94e-05	0.00196	CbGeAlD
Tretinoin—CYP1A1—endocrine gland—breast cancer	9.46e-05	0.00186	CbGeAlD
Tretinoin—CYP3A5—endocrine gland—breast cancer	9.25e-05	0.00182	CbGeAlD
Tretinoin—CYP2B6—endocrine gland—breast cancer	9.19e-05	0.00181	CbGeAlD
Tretinoin—CYP2C9—endocrine gland—breast cancer	9.1e-05	0.00179	CbGeAlD
Tretinoin—CYP3A4—female reproductive system—breast cancer	8.2e-05	0.00162	CbGeAlD
Tretinoin—Vitamin A—CYP1A1—breast cancer	7.55e-05	0.02	CrCbGaD
Tretinoin—CYP3A4—endocrine gland—breast cancer	6.94e-05	0.00137	CbGeAlD
Tretinoin—CYP1A1—lymph node—breast cancer	6.54e-05	0.00129	CbGeAlD
Tretinoin—Acitretin—ALB—breast cancer	6.01e-05	0.0159	CrCbGaD
Tretinoin—Alitretinoin—ABCB1—breast cancer	5.5e-05	0.0146	CrCbGaD
Tretinoin—Insomnia—Capecitabine—breast cancer	1.18e-05	8.84e-05	CcSEcCtD
Tretinoin—Hypoaesthesia—Doxorubicin—breast cancer	1.17e-05	8.83e-05	CcSEcCtD
Tretinoin—Rash—Fluorouracil—breast cancer	1.17e-05	8.82e-05	CcSEcCtD
Tretinoin—Dermatitis—Fluorouracil—breast cancer	1.17e-05	8.81e-05	CcSEcCtD
Tretinoin—Pharyngitis—Doxorubicin—breast cancer	1.17e-05	8.8e-05	CcSEcCtD
Tretinoin—Paraesthesia—Capecitabine—breast cancer	1.17e-05	8.78e-05	CcSEcCtD
Tretinoin—Decreased appetite—Docetaxel—breast cancer	1.17e-05	8.78e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Paclitaxel—breast cancer	1.17e-05	8.78e-05	CcSEcCtD
Tretinoin—Headache—Fluorouracil—breast cancer	1.17e-05	8.77e-05	CcSEcCtD
Tretinoin—Urinary tract disorder—Doxorubicin—breast cancer	1.17e-05	8.76e-05	CcSEcCtD
Tretinoin—Oedema peripheral—Doxorubicin—breast cancer	1.16e-05	8.74e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Docetaxel—breast cancer	1.16e-05	8.72e-05	CcSEcCtD
Tretinoin—Dyspnoea—Capecitabine—breast cancer	1.16e-05	8.72e-05	CcSEcCtD
Tretinoin—Fatigue—Docetaxel—breast cancer	1.16e-05	8.71e-05	CcSEcCtD
Tretinoin—Angiopathy—Epirubicin—breast cancer	1.16e-05	8.7e-05	CcSEcCtD
Tretinoin—Urethral disorder—Doxorubicin—breast cancer	1.16e-05	8.7e-05	CcSEcCtD
Tretinoin—Nausea—Irinotecan—breast cancer	1.15e-05	8.68e-05	CcSEcCtD
Tretinoin—Nausea—Mitoxantrone—breast cancer	1.15e-05	8.68e-05	CcSEcCtD
Tretinoin—Pain—Docetaxel—breast cancer	1.15e-05	8.64e-05	CcSEcCtD
Tretinoin—Constipation—Docetaxel—breast cancer	1.15e-05	8.64e-05	CcSEcCtD
Tretinoin—Back pain—Methotrexate—breast cancer	1.15e-05	8.63e-05	CcSEcCtD
Tretinoin—Dyspepsia—Capecitabine—breast cancer	1.14e-05	8.61e-05	CcSEcCtD
Tretinoin—Chills—Epirubicin—breast cancer	1.14e-05	8.6e-05	CcSEcCtD
Tretinoin—Arrhythmia—Epirubicin—breast cancer	1.14e-05	8.57e-05	CcSEcCtD
Tretinoin—Visual impairment—Doxorubicin—breast cancer	1.14e-05	8.55e-05	CcSEcCtD
Tretinoin—Asthenia—Paclitaxel—breast cancer	1.14e-05	8.55e-05	CcSEcCtD
Tretinoin—Decreased appetite—Capecitabine—breast cancer	1.13e-05	8.5e-05	CcSEcCtD
Tretinoin—Alopecia—Epirubicin—breast cancer	1.13e-05	8.47e-05	CcSEcCtD
Tretinoin—Nausea—Gemcitabine—breast cancer	1.12e-05	8.45e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Capecitabine—breast cancer	1.12e-05	8.44e-05	CcSEcCtD
Tretinoin—Fatigue—Capecitabine—breast cancer	1.12e-05	8.43e-05	CcSEcCtD
Tretinoin—Pruritus—Paclitaxel—breast cancer	1.12e-05	8.43e-05	CcSEcCtD
Tretinoin—Vision blurred—Methotrexate—breast cancer	1.12e-05	8.41e-05	CcSEcCtD
Tretinoin—Mental disorder—Epirubicin—breast cancer	1.12e-05	8.4e-05	CcSEcCtD
Tretinoin—Erythema multiforme—Doxorubicin—breast cancer	1.12e-05	8.39e-05	CcSEcCtD
Tretinoin—Pain—Capecitabine—breast cancer	1.11e-05	8.36e-05	CcSEcCtD
Tretinoin—Constipation—Capecitabine—breast cancer	1.11e-05	8.36e-05	CcSEcCtD
Tretinoin—Erythema—Epirubicin—breast cancer	1.11e-05	8.35e-05	CcSEcCtD
Tretinoin—Malnutrition—Epirubicin—breast cancer	1.11e-05	8.35e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Docetaxel—breast cancer	1.11e-05	8.32e-05	CcSEcCtD
Tretinoin—Nausea—Fluorouracil—breast cancer	1.11e-05	8.31e-05	CcSEcCtD
Tretinoin—Eye disorder—Doxorubicin—breast cancer	1.1e-05	8.29e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Methotrexate—breast cancer	1.1e-05	8.28e-05	CcSEcCtD
Tretinoin—Tinnitus—Doxorubicin—breast cancer	1.1e-05	8.27e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Docetaxel—breast cancer	1.1e-05	8.26e-05	CcSEcCtD
Tretinoin—Anaemia—Methotrexate—breast cancer	1.1e-05	8.24e-05	CcSEcCtD
Tretinoin—Flushing—Doxorubicin—breast cancer	1.1e-05	8.23e-05	CcSEcCtD
Tretinoin—Flatulence—Epirubicin—breast cancer	1.09e-05	8.22e-05	CcSEcCtD
Tretinoin—Tension—Epirubicin—breast cancer	1.09e-05	8.19e-05	CcSEcCtD
Tretinoin—Diarrhoea—Paclitaxel—breast cancer	1.08e-05	8.15e-05	CcSEcCtD
Tretinoin—Nervousness—Epirubicin—breast cancer	1.08e-05	8.11e-05	CcSEcCtD
Tretinoin—Back pain—Epirubicin—breast cancer	1.07e-05	8.07e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Capecitabine—breast cancer	1.07e-05	8.06e-05	CcSEcCtD
Tretinoin—Angiopathy—Doxorubicin—breast cancer	1.07e-05	8.05e-05	CcSEcCtD
Tretinoin—Malaise—Methotrexate—breast cancer	1.07e-05	8.04e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Capecitabine—breast cancer	1.06e-05	8e-05	CcSEcCtD
Tretinoin—Abdominal pain—Docetaxel—breast cancer	1.06e-05	7.98e-05	CcSEcCtD
Tretinoin—Body temperature increased—Docetaxel—breast cancer	1.06e-05	7.98e-05	CcSEcCtD
Tretinoin—Chills—Doxorubicin—breast cancer	1.06e-05	7.96e-05	CcSEcCtD
Tretinoin—Arrhythmia—Doxorubicin—breast cancer	1.05e-05	7.93e-05	CcSEcCtD
Tretinoin—Dizziness—Paclitaxel—breast cancer	1.05e-05	7.88e-05	CcSEcCtD
Tretinoin—Vision blurred—Epirubicin—breast cancer	1.05e-05	7.87e-05	CcSEcCtD
Tretinoin—Alopecia—Doxorubicin—breast cancer	1.04e-05	7.84e-05	CcSEcCtD
Tretinoin—Cough—Methotrexate—breast cancer	1.04e-05	7.78e-05	CcSEcCtD
Tretinoin—Mental disorder—Doxorubicin—breast cancer	1.03e-05	7.77e-05	CcSEcCtD
Tretinoin—Urticaria—Capecitabine—breast cancer	1.03e-05	7.77e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Epirubicin—breast cancer	1.03e-05	7.74e-05	CcSEcCtD
Tretinoin—Abdominal pain—Capecitabine—breast cancer	1.03e-05	7.73e-05	CcSEcCtD
Tretinoin—Body temperature increased—Capecitabine—breast cancer	1.03e-05	7.73e-05	CcSEcCtD
Tretinoin—Convulsion—Methotrexate—breast cancer	1.03e-05	7.73e-05	CcSEcCtD
Tretinoin—Erythema—Doxorubicin—breast cancer	1.03e-05	7.72e-05	CcSEcCtD
Tretinoin—Malnutrition—Doxorubicin—breast cancer	1.03e-05	7.72e-05	CcSEcCtD
Tretinoin—Anaemia—Epirubicin—breast cancer	1.03e-05	7.71e-05	CcSEcCtD
Tretinoin—Agitation—Epirubicin—breast cancer	1.02e-05	7.67e-05	CcSEcCtD
Tretinoin—Flatulence—Doxorubicin—breast cancer	1.01e-05	7.61e-05	CcSEcCtD
Tretinoin—Myalgia—Methotrexate—breast cancer	1.01e-05	7.59e-05	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—breast cancer	1.01e-05	7.59e-05	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—breast cancer	1.01e-05	7.59e-05	CcSEcCtD
Tretinoin—Tension—Doxorubicin—breast cancer	1.01e-05	7.58e-05	CcSEcCtD
Tretinoin—Vomiting—Paclitaxel—breast cancer	1.01e-05	7.58e-05	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1e-05	7.54e-05	CcSEcCtD
Tretinoin—Malaise—Epirubicin—breast cancer	1e-05	7.53e-05	CcSEcCtD
Tretinoin—Rash—Paclitaxel—breast cancer	9.99e-06	7.51e-05	CcSEcCtD
Tretinoin—Dermatitis—Paclitaxel—breast cancer	9.98e-06	7.51e-05	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—breast cancer	9.98e-06	7.5e-05	CcSEcCtD
Tretinoin—Nervousness—Doxorubicin—breast cancer	9.98e-06	7.5e-05	CcSEcCtD
Tretinoin—Syncope—Epirubicin—breast cancer	9.96e-06	7.48e-05	CcSEcCtD
Tretinoin—Back pain—Doxorubicin—breast cancer	9.94e-06	7.47e-05	CcSEcCtD
Tretinoin—Headache—Paclitaxel—breast cancer	9.93e-06	7.46e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Docetaxel—breast cancer	9.9e-06	7.44e-05	CcSEcCtD
Tretinoin—Palpitations—Epirubicin—breast cancer	9.81e-06	7.38e-05	CcSEcCtD
Tretinoin—Confusional state—Methotrexate—breast cancer	9.76e-06	7.34e-05	CcSEcCtD
Tretinoin—Loss of consciousness—Epirubicin—breast cancer	9.76e-06	7.34e-05	CcSEcCtD
Tretinoin—Cough—Epirubicin—breast cancer	9.69e-06	7.28e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Methotrexate—breast cancer	9.68e-06	7.28e-05	CcSEcCtD
Tretinoin—Vision blurred—Doxorubicin—breast cancer	9.68e-06	7.28e-05	CcSEcCtD
Tretinoin—Asthenia—Docetaxel—breast cancer	9.64e-06	7.25e-05	CcSEcCtD
Tretinoin—Convulsion—Epirubicin—breast cancer	9.62e-06	7.23e-05	CcSEcCtD
Tretinoin—Infection—Methotrexate—breast cancer	9.62e-06	7.23e-05	CcSEcCtD
Tretinoin—Hypertension—Epirubicin—breast cancer	9.59e-06	7.21e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Capecitabine—breast cancer	9.58e-06	7.2e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Doxorubicin—breast cancer	9.53e-06	7.17e-05	CcSEcCtD
Tretinoin—Pruritus—Docetaxel—breast cancer	9.51e-06	7.15e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Methotrexate—breast cancer	9.5e-06	7.14e-05	CcSEcCtD
Tretinoin—Anaemia—Doxorubicin—breast cancer	9.5e-06	7.14e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—breast cancer	9.48e-06	7.13e-05	CcSEcCtD
Tretinoin—Myalgia—Epirubicin—breast cancer	9.45e-06	7.11e-05	CcSEcCtD
Tretinoin—Chest pain—Epirubicin—breast cancer	9.45e-06	7.11e-05	CcSEcCtD
Tretinoin—Arthralgia—Epirubicin—breast cancer	9.45e-06	7.11e-05	CcSEcCtD
Tretinoin—Agitation—Doxorubicin—breast cancer	9.44e-06	7.1e-05	CcSEcCtD
Tretinoin—Anxiety—Epirubicin—breast cancer	9.42e-06	7.08e-05	CcSEcCtD
Tretinoin—Nausea—Paclitaxel—breast cancer	9.41e-06	7.08e-05	CcSEcCtD
Tretinoin—Skin disorder—Methotrexate—breast cancer	9.41e-06	7.07e-05	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	9.39e-06	7.06e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—breast cancer	9.36e-06	7.04e-05	CcSEcCtD
Tretinoin—Discomfort—Epirubicin—breast cancer	9.34e-06	7.02e-05	CcSEcCtD
Tretinoin—Asthenia—Capecitabine—breast cancer	9.33e-06	7.02e-05	CcSEcCtD
Tretinoin—Malaise—Doxorubicin—breast cancer	9.26e-06	6.96e-05	CcSEcCtD
Tretinoin—Dry mouth—Epirubicin—breast cancer	9.24e-06	6.95e-05	CcSEcCtD
Tretinoin—Anorexia—Methotrexate—breast cancer	9.23e-06	6.94e-05	CcSEcCtD
Tretinoin—Syncope—Doxorubicin—breast cancer	9.21e-06	6.93e-05	CcSEcCtD
Tretinoin—Pruritus—Capecitabine—breast cancer	9.2e-06	6.92e-05	CcSEcCtD
Tretinoin—Diarrhoea—Docetaxel—breast cancer	9.19e-06	6.91e-05	CcSEcCtD
Tretinoin—Confusional state—Epirubicin—breast cancer	9.14e-06	6.87e-05	CcSEcCtD
Tretinoin—Palpitations—Doxorubicin—breast cancer	9.08e-06	6.82e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Epirubicin—breast cancer	9.06e-06	6.81e-05	CcSEcCtD
Tretinoin—Oedema—Epirubicin—breast cancer	9.06e-06	6.81e-05	CcSEcCtD
Tretinoin—Hypotension—Methotrexate—breast cancer	9.05e-06	6.8e-05	CcSEcCtD
Tretinoin—Loss of consciousness—Doxorubicin—breast cancer	9.03e-06	6.79e-05	CcSEcCtD
Tretinoin—Infection—Epirubicin—breast cancer	9e-06	6.77e-05	CcSEcCtD
Tretinoin—Cough—Doxorubicin—breast cancer	8.96e-06	6.74e-05	CcSEcCtD
Tretinoin—Shock—Epirubicin—breast cancer	8.92e-06	6.7e-05	CcSEcCtD
Tretinoin—Convulsion—Doxorubicin—breast cancer	8.9e-06	6.69e-05	CcSEcCtD
Tretinoin—Diarrhoea—Capecitabine—breast cancer	8.9e-06	6.69e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Epirubicin—breast cancer	8.89e-06	6.68e-05	CcSEcCtD
Tretinoin—Dizziness—Docetaxel—breast cancer	8.88e-06	6.68e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Epirubicin—breast cancer	8.87e-06	6.67e-05	CcSEcCtD
Tretinoin—Hypertension—Doxorubicin—breast cancer	8.87e-06	6.67e-05	CcSEcCtD
Tretinoin—Tachycardia—Epirubicin—breast cancer	8.84e-06	6.65e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methotrexate—breast cancer	8.82e-06	6.63e-05	CcSEcCtD
Tretinoin—Skin disorder—Epirubicin—breast cancer	8.8e-06	6.62e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Epirubicin—breast cancer	8.76e-06	6.59e-05	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—breast cancer	8.76e-06	6.58e-05	CcSEcCtD
Tretinoin—Chest pain—Doxorubicin—breast cancer	8.75e-06	6.57e-05	CcSEcCtD
Tretinoin—Myalgia—Doxorubicin—breast cancer	8.75e-06	6.57e-05	CcSEcCtD
Tretinoin—Arthralgia—Doxorubicin—breast cancer	8.75e-06	6.57e-05	CcSEcCtD
Tretinoin—Anxiety—Doxorubicin—breast cancer	8.72e-06	6.55e-05	CcSEcCtD
Tretinoin—Paraesthesia—Methotrexate—breast cancer	8.69e-06	6.54e-05	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	8.69e-06	6.53e-05	CcSEcCtD
Tretinoin—Discomfort—Doxorubicin—breast cancer	8.64e-06	6.5e-05	CcSEcCtD
Tretinoin—Anorexia—Epirubicin—breast cancer	8.64e-06	6.49e-05	CcSEcCtD
Tretinoin—Dyspnoea—Methotrexate—breast cancer	8.63e-06	6.49e-05	CcSEcCtD
Tretinoin—Somnolence—Methotrexate—breast cancer	8.61e-06	6.47e-05	CcSEcCtD
Tretinoin—Dizziness—Capecitabine—breast cancer	8.6e-06	6.47e-05	CcSEcCtD
Tretinoin—Dry mouth—Doxorubicin—breast cancer	8.55e-06	6.43e-05	CcSEcCtD
Tretinoin—Vomiting—Docetaxel—breast cancer	8.54e-06	6.42e-05	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—breast cancer	8.52e-06	6.41e-05	CcSEcCtD
Tretinoin—Rash—Docetaxel—breast cancer	8.47e-06	6.37e-05	CcSEcCtD
Tretinoin—Hypotension—Epirubicin—breast cancer	8.47e-06	6.37e-05	CcSEcCtD
Tretinoin—Dermatitis—Docetaxel—breast cancer	8.46e-06	6.36e-05	CcSEcCtD
Tretinoin—Confusional state—Doxorubicin—breast cancer	8.45e-06	6.36e-05	CcSEcCtD
Tretinoin—Decreased appetite—Methotrexate—breast cancer	8.42e-06	6.33e-05	CcSEcCtD
Tretinoin—Headache—Docetaxel—breast cancer	8.42e-06	6.33e-05	CcSEcCtD
Tretinoin—Oedema—Doxorubicin—breast cancer	8.38e-06	6.3e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Doxorubicin—breast cancer	8.38e-06	6.3e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Methotrexate—breast cancer	8.36e-06	6.28e-05	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—breast cancer	8.35e-06	6.28e-05	CcSEcCtD
Tretinoin—Infection—Doxorubicin—breast cancer	8.33e-06	6.26e-05	CcSEcCtD
Tretinoin—Pain—Methotrexate—breast cancer	8.28e-06	6.22e-05	CcSEcCtD
Tretinoin—Vomiting—Capecitabine—breast cancer	8.27e-06	6.22e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Epirubicin—breast cancer	8.26e-06	6.21e-05	CcSEcCtD
Tretinoin—Shock—Doxorubicin—breast cancer	8.25e-06	6.2e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Doxorubicin—breast cancer	8.22e-06	6.18e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Doxorubicin—breast cancer	8.21e-06	6.17e-05	CcSEcCtD
Tretinoin—Rash—Capecitabine—breast cancer	8.2e-06	6.17e-05	CcSEcCtD
Tretinoin—Insomnia—Epirubicin—breast cancer	8.2e-06	6.16e-05	CcSEcCtD
Tretinoin—Dermatitis—Capecitabine—breast cancer	8.19e-06	6.16e-05	CcSEcCtD
Tretinoin—Tachycardia—Doxorubicin—breast cancer	8.18e-06	6.15e-05	CcSEcCtD
Tretinoin—Headache—Capecitabine—breast cancer	8.15e-06	6.13e-05	CcSEcCtD
Tretinoin—Skin disorder—Doxorubicin—breast cancer	8.14e-06	6.12e-05	CcSEcCtD
Tretinoin—Paraesthesia—Epirubicin—breast cancer	8.14e-06	6.12e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Doxorubicin—breast cancer	8.11e-06	6.09e-05	CcSEcCtD
Tretinoin—Dyspnoea—Epirubicin—breast cancer	8.08e-06	6.07e-05	CcSEcCtD
Tretinoin—Somnolence—Epirubicin—breast cancer	8.06e-06	6.06e-05	CcSEcCtD
Tretinoin—Anorexia—Doxorubicin—breast cancer	7.99e-06	6.01e-05	CcSEcCtD
Tretinoin—Nausea—Docetaxel—breast cancer	7.98e-06	6e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Methotrexate—breast cancer	7.98e-06	6e-05	CcSEcCtD
Tretinoin—Dyspepsia—Epirubicin—breast cancer	7.98e-06	6e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methotrexate—breast cancer	7.92e-06	5.95e-05	CcSEcCtD
Tretinoin—Decreased appetite—Epirubicin—breast cancer	7.88e-06	5.92e-05	CcSEcCtD
Tretinoin—Hypotension—Doxorubicin—breast cancer	7.83e-06	5.89e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Epirubicin—breast cancer	7.82e-06	5.88e-05	CcSEcCtD
Tretinoin—Fatigue—Epirubicin—breast cancer	7.81e-06	5.87e-05	CcSEcCtD
Tretinoin—Pain—Epirubicin—breast cancer	7.75e-06	5.83e-05	CcSEcCtD
Tretinoin—Constipation—Epirubicin—breast cancer	7.75e-06	5.83e-05	CcSEcCtD
Tretinoin—Nausea—Capecitabine—breast cancer	7.73e-06	5.81e-05	CcSEcCtD
Tretinoin—Urticaria—Methotrexate—breast cancer	7.69e-06	5.78e-05	CcSEcCtD
Tretinoin—Abdominal pain—Methotrexate—breast cancer	7.65e-06	5.75e-05	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—breast cancer	7.65e-06	5.75e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Doxorubicin—breast cancer	7.64e-06	5.74e-05	CcSEcCtD
Tretinoin—Insomnia—Doxorubicin—breast cancer	7.58e-06	5.7e-05	CcSEcCtD
Tretinoin—Paraesthesia—Doxorubicin—breast cancer	7.53e-06	5.66e-05	CcSEcCtD
Tretinoin—Dyspnoea—Doxorubicin—breast cancer	7.48e-06	5.62e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Epirubicin—breast cancer	7.47e-06	5.61e-05	CcSEcCtD
Tretinoin—Somnolence—Doxorubicin—breast cancer	7.45e-06	5.6e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Epirubicin—breast cancer	7.41e-06	5.57e-05	CcSEcCtD
Tretinoin—Dyspepsia—Doxorubicin—breast cancer	7.38e-06	5.55e-05	CcSEcCtD
Tretinoin—Decreased appetite—Doxorubicin—breast cancer	7.29e-06	5.48e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Doxorubicin—breast cancer	7.24e-06	5.44e-05	CcSEcCtD
Tretinoin—Fatigue—Doxorubicin—breast cancer	7.23e-06	5.43e-05	CcSEcCtD
Tretinoin—Urticaria—Epirubicin—breast cancer	7.2e-06	5.41e-05	CcSEcCtD
Tretinoin—Pain—Doxorubicin—breast cancer	7.17e-06	5.39e-05	CcSEcCtD
Tretinoin—Constipation—Doxorubicin—breast cancer	7.17e-06	5.39e-05	CcSEcCtD
Tretinoin—Abdominal pain—Epirubicin—breast cancer	7.16e-06	5.38e-05	CcSEcCtD
Tretinoin—Body temperature increased—Epirubicin—breast cancer	7.16e-06	5.38e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Methotrexate—breast cancer	7.13e-06	5.36e-05	CcSEcCtD
Tretinoin—Asthenia—Methotrexate—breast cancer	6.95e-06	5.22e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Doxorubicin—breast cancer	6.91e-06	5.19e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Doxorubicin—breast cancer	6.86e-06	5.15e-05	CcSEcCtD
Tretinoin—Pruritus—Methotrexate—breast cancer	6.85e-06	5.15e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Epirubicin—breast cancer	6.68e-06	5.02e-05	CcSEcCtD
Tretinoin—Urticaria—Doxorubicin—breast cancer	6.66e-06	5.01e-05	CcSEcCtD
Tretinoin—Body temperature increased—Doxorubicin—breast cancer	6.63e-06	4.98e-05	CcSEcCtD
Tretinoin—Abdominal pain—Doxorubicin—breast cancer	6.63e-06	4.98e-05	CcSEcCtD
Tretinoin—Diarrhoea—Methotrexate—breast cancer	6.63e-06	4.98e-05	CcSEcCtD
Tretinoin—Asthenia—Epirubicin—breast cancer	6.5e-06	4.89e-05	CcSEcCtD
Tretinoin—Pruritus—Epirubicin—breast cancer	6.41e-06	4.82e-05	CcSEcCtD
Tretinoin—Dizziness—Methotrexate—breast cancer	6.4e-06	4.81e-05	CcSEcCtD
Tretinoin—Diarrhoea—Epirubicin—breast cancer	6.2e-06	4.66e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Doxorubicin—breast cancer	6.18e-06	4.64e-05	CcSEcCtD
Tretinoin—Vomiting—Methotrexate—breast cancer	6.16e-06	4.63e-05	CcSEcCtD
Tretinoin—Rash—Methotrexate—breast cancer	6.11e-06	4.59e-05	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—breast cancer	6.1e-06	4.59e-05	CcSEcCtD
Tretinoin—Headache—Methotrexate—breast cancer	6.07e-06	4.56e-05	CcSEcCtD
Tretinoin—Asthenia—Doxorubicin—breast cancer	6.02e-06	4.52e-05	CcSEcCtD
Tretinoin—Dizziness—Epirubicin—breast cancer	5.99e-06	4.5e-05	CcSEcCtD
Tretinoin—Pruritus—Doxorubicin—breast cancer	5.93e-06	4.46e-05	CcSEcCtD
Tretinoin—Vomiting—Epirubicin—breast cancer	5.76e-06	4.33e-05	CcSEcCtD
Tretinoin—Nausea—Methotrexate—breast cancer	5.75e-06	4.32e-05	CcSEcCtD
Tretinoin—Diarrhoea—Doxorubicin—breast cancer	5.74e-06	4.31e-05	CcSEcCtD
Tretinoin—Rash—Epirubicin—breast cancer	5.71e-06	4.29e-05	CcSEcCtD
Tretinoin—Dermatitis—Epirubicin—breast cancer	5.71e-06	4.29e-05	CcSEcCtD
Tretinoin—Headache—Epirubicin—breast cancer	5.68e-06	4.27e-05	CcSEcCtD
Tretinoin—Dizziness—Doxorubicin—breast cancer	5.54e-06	4.17e-05	CcSEcCtD
Tretinoin—Nausea—Epirubicin—breast cancer	5.38e-06	4.05e-05	CcSEcCtD
Tretinoin—Vomiting—Doxorubicin—breast cancer	5.33e-06	4.01e-05	CcSEcCtD
Tretinoin—Rash—Doxorubicin—breast cancer	5.29e-06	3.97e-05	CcSEcCtD
Tretinoin—Dermatitis—Doxorubicin—breast cancer	5.28e-06	3.97e-05	CcSEcCtD
Tretinoin—Headache—Doxorubicin—breast cancer	5.25e-06	3.95e-05	CcSEcCtD
Tretinoin—Nausea—Doxorubicin—breast cancer	4.98e-06	3.74e-05	CcSEcCtD
Tretinoin—CYP3A7—Metabolism—CAV1—breast cancer	9.55e-07	8.83e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NCOA1—breast cancer	9.55e-07	8.83e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—MTHFR—breast cancer	9.49e-07	8.78e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—COMT—breast cancer	9.47e-07	8.76e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTP1—breast cancer	9.43e-07	8.72e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—STK11—breast cancer	9.41e-07	8.7e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYP19A1—breast cancer	9.41e-07	8.7e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCC1—breast cancer	9.38e-07	8.67e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMMR—breast cancer	9.38e-07	8.67e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA3—breast cancer	9.38e-07	8.67e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ACHE—breast cancer	9.37e-07	8.67e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTT1—breast cancer	9.37e-07	8.67e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	9.37e-07	8.67e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP3A4—breast cancer	9.33e-07	8.63e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HMOX1—breast cancer	9.3e-07	8.6e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	9.29e-07	8.59e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ITPR1—breast cancer	9.28e-07	8.58e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—COMT—breast cancer	9.26e-07	8.56e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTP1—breast cancer	9.22e-07	8.52e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1B1—breast cancer	9.18e-07	8.49e-06	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CB—breast cancer	9.1e-07	8.41e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HMOX1—breast cancer	9.09e-07	8.41e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PPARGC1B—breast cancer	9.08e-07	8.4e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ITPR1—breast cancer	9.07e-07	8.39e-06	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTGS2—breast cancer	9.02e-07	8.34e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HSP90AA1—breast cancer	9e-07	8.32e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCB1—breast cancer	8.93e-07	8.25e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP17A1—breast cancer	8.87e-07	8.2e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.83e-07	8.17e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ENO1—breast cancer	8.78e-07	8.12e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS1—breast cancer	8.78e-07	8.12e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—TYMS—breast cancer	8.77e-07	8.11e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CAV1—breast cancer	8.76e-07	8.1e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NCOA1—breast cancer	8.75e-07	8.09e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.75e-07	8.09e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—COMT—breast cancer	8.75e-07	8.09e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCB1—breast cancer	8.72e-07	8.07e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTP1—breast cancer	8.71e-07	8.05e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CG—breast cancer	8.7e-07	8.05e-06	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTEN—breast cancer	8.67e-07	8.01e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PLA2G4A—breast cancer	8.67e-07	8.01e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTM1—breast cancer	8.67e-07	8.01e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NCOR1—breast cancer	8.67e-07	8.01e-06	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MAPK3—breast cancer	8.64e-07	7.99e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.64e-07	7.99e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—STK11—breast cancer	8.63e-07	7.98e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP19A1—breast cancer	8.63e-07	7.98e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP2D6—breast cancer	8.61e-07	7.97e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HMOX1—breast cancer	8.59e-07	7.94e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CA9—breast cancer	8.58e-07	7.93e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA4—breast cancer	8.58e-07	7.93e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—TYMS—breast cancer	8.57e-07	7.92e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ITPR1—breast cancer	8.57e-07	7.92e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTM1—breast cancer	8.47e-07	7.83e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PLA2G4A—breast cancer	8.47e-07	7.83e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NCOR1—breast cancer	8.47e-07	7.83e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NCOA2—breast cancer	8.46e-07	7.82e-06	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—breast cancer	8.4e-07	7.77e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA2—breast cancer	8.36e-07	7.73e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPX2—breast cancer	8.36e-07	7.73e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GPX1—breast cancer	8.3e-07	7.67e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SULT1A1—breast cancer	8.26e-07	7.63e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPX4—breast cancer	8.26e-07	7.63e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCB1—breast cancer	8.24e-07	7.62e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYP1A1—breast cancer	8.21e-07	7.6e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—FASN—breast cancer	8.2e-07	7.58e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—BCHE—breast cancer	8.17e-07	7.55e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ERCC2—breast cancer	8.15e-07	7.53e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GPX1—breast cancer	8.11e-07	7.5e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.1e-07	7.49e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—TYMS—breast cancer	8.1e-07	7.49e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC5A5—breast cancer	8.07e-07	7.46e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—IDH1—breast cancer	8.06e-07	7.46e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTA1—breast cancer	8.06e-07	7.46e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYP1A1—breast cancer	8.03e-07	7.42e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—COMT—breast cancer	8.02e-07	7.42e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTM1—breast cancer	8e-07	7.4e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NCOR1—breast cancer	8e-07	7.4e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PLA2G4A—breast cancer	8e-07	7.4e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTP1—breast cancer	7.98e-07	7.38e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CG—breast cancer	7.97e-07	7.37e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NAT2—breast cancer	7.97e-07	7.37e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ERCC2—breast cancer	7.96e-07	7.36e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HMOX1—breast cancer	7.87e-07	7.28e-06	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTEN—breast cancer	7.86e-07	7.27e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ITPR1—breast cancer	7.86e-07	7.26e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NQO1—breast cancer	7.79e-07	7.2e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC2A1—breast cancer	7.79e-07	7.2e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GPX1—breast cancer	7.66e-07	7.09e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—MTHFR—breast cancer	7.66e-07	7.08e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CD—breast cancer	7.65e-07	7.07e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.63e-07	7.05e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP3A4—breast cancer	7.6e-07	7.02e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.56e-07	6.99e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCB1—breast cancer	7.56e-07	6.99e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—breast cancer	7.55e-07	6.98e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ERCC2—breast cancer	7.52e-07	6.96e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—MTHFR—breast cancer	7.49e-07	6.92e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1B1—breast cancer	7.47e-07	6.91e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—TYMS—breast cancer	7.42e-07	6.86e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NCOR1—breast cancer	7.34e-07	6.78e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PLA2G4A—breast cancer	7.34e-07	6.78e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTM1—breast cancer	7.34e-07	6.78e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HSP90AA1—breast cancer	7.32e-07	6.77e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NOS3—breast cancer	7.22e-07	6.68e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NCOA1—breast cancer	7.13e-07	6.59e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—MTHFR—breast cancer	7.07e-07	6.54e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CAV1—breast cancer	7.06e-07	6.53e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GPX1—breast cancer	7.03e-07	6.5e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—STK11—breast cancer	7.02e-07	6.49e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP19A1—breast cancer	7.02e-07	6.49e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CD—breast cancer	7.01e-07	6.48e-06	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—breast cancer	6.99e-07	6.47e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MED12—breast cancer	6.99e-07	6.46e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—DPYD—breast cancer	6.99e-07	6.46e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYP1A1—breast cancer	6.95e-07	6.43e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—breast cancer	6.92e-07	6.4e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CAV1—breast cancer	6.9e-07	6.38e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ERCC2—breast cancer	6.9e-07	6.38e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALDOA—breast cancer	6.88e-07	6.36e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOA3—breast cancer	6.68e-07	6.18e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CB—breast cancer	6.67e-07	6.16e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A2—breast cancer	6.63e-07	6.13e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NOS3—breast cancer	6.62e-07	6.12e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTGS2—breast cancer	6.61e-07	6.11e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.59e-07	6.09e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—COMT—breast cancer	6.53e-07	6.04e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CAV1—breast cancer	6.52e-07	6.03e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CPT1A—breast cancer	6.5e-07	6.01e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCG2—breast cancer	6.5e-07	6.01e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTR—breast cancer	6.5e-07	6.01e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTP1—breast cancer	6.5e-07	6.01e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MTHFR—breast cancer	6.48e-07	6e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CG—breast cancer	6.43e-07	5.95e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HMOX1—breast cancer	6.41e-07	5.93e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ITPR1—breast cancer	6.39e-07	5.91e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HPGDS—breast cancer	6.37e-07	5.89e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HBA1—breast cancer	6.33e-07	5.86e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CG—breast cancer	6.29e-07	5.82e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.23e-07	5.76e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTT1—breast cancer	6.18e-07	5.72e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ACHE—breast cancer	6.18e-07	5.72e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCB1—breast cancer	6.15e-07	5.69e-06	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—breast cancer	6.11e-07	5.65e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CB—breast cancer	6.11e-07	5.65e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTGS2—breast cancer	6.05e-07	5.6e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TYMS—breast cancer	6.04e-07	5.59e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CAV1—breast cancer	5.98e-07	5.53e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTM1—breast cancer	5.97e-07	5.52e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NCOR1—breast cancer	5.97e-07	5.52e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PLA2G4A—breast cancer	5.97e-07	5.52e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CG—breast cancer	5.94e-07	5.49e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP17A1—breast cancer	5.85e-07	5.41e-06	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—breast cancer	5.83e-07	5.39e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ENO1—breast cancer	5.79e-07	5.36e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS1—breast cancer	5.79e-07	5.36e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTEN—breast cancer	5.76e-07	5.33e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GPX1—breast cancer	5.72e-07	5.29e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.71e-07	5.28e-06	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—breast cancer	5.71e-07	5.28e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP2D6—breast cancer	5.68e-07	5.25e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYP1A1—breast cancer	5.66e-07	5.23e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CD—breast cancer	5.66e-07	5.23e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ERCC2—breast cancer	5.61e-07	5.19e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—breast cancer	5.58e-07	5.16e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOA2—breast cancer	5.58e-07	5.16e-06	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—breast cancer	5.55e-07	5.13e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CD—breast cancer	5.53e-07	5.11e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—breast cancer	5.46e-07	5.05e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CG—breast cancer	5.45e-07	5.04e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—FASN—breast cancer	5.41e-07	5e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—BCHE—breast cancer	5.39e-07	4.98e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NOS3—breast cancer	5.34e-07	4.94e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC5A5—breast cancer	5.32e-07	4.92e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTEN—breast cancer	5.28e-07	4.88e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MTHFR—breast cancer	5.28e-07	4.88e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CD—breast cancer	5.22e-07	4.83e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NOS3—breast cancer	5.22e-07	4.83e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—breast cancer	5.16e-07	4.77e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC2A1—breast cancer	5.14e-07	4.75e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NQO1—breast cancer	5.14e-07	4.75e-06	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—breast cancer	4.99e-07	4.62e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NOS3—breast cancer	4.93e-07	4.56e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CB—breast cancer	4.93e-07	4.56e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1B1—breast cancer	4.93e-07	4.55e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTGS2—breast cancer	4.89e-07	4.52e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CAV1—breast cancer	4.87e-07	4.5e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.83e-07	4.47e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CB—breast cancer	4.82e-07	4.46e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CD—breast cancer	4.79e-07	4.43e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTGS2—breast cancer	4.78e-07	4.42e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—breast cancer	4.73e-07	4.37e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOA1—breast cancer	4.7e-07	4.34e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.65e-07	4.3e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP19A1—breast cancer	4.63e-07	4.28e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—STK11—breast cancer	4.63e-07	4.28e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CB—breast cancer	4.55e-07	4.21e-06	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—breast cancer	4.53e-07	4.19e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NOS3—breast cancer	4.52e-07	4.18e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTGS2—breast cancer	4.51e-07	4.17e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CG—breast cancer	4.43e-07	4.1e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—COMT—breast cancer	4.31e-07	3.98e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTP1—breast cancer	4.29e-07	3.96e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTEN—breast cancer	4.26e-07	3.94e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMOX1—breast cancer	4.23e-07	3.91e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ITPR1—breast cancer	4.22e-07	3.9e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CB—breast cancer	4.17e-07	3.86e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTEN—breast cancer	4.16e-07	3.85e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTGS2—breast cancer	4.14e-07	3.82e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—breast cancer	4.06e-07	3.76e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCB1—breast cancer	4.06e-07	3.75e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TYMS—breast cancer	3.98e-07	3.68e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTM1—breast cancer	3.94e-07	3.64e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOR1—breast cancer	3.94e-07	3.64e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.94e-07	3.64e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTEN—breast cancer	3.93e-07	3.64e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CD—breast cancer	3.9e-07	3.6e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—breast cancer	3.85e-07	3.56e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GPX1—breast cancer	3.77e-07	3.49e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYP1A1—breast cancer	3.73e-07	3.45e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—breast cancer	3.73e-07	3.44e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ERCC2—breast cancer	3.7e-07	3.42e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NOS3—breast cancer	3.68e-07	3.4e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTEN—breast cancer	3.61e-07	3.34e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTHFR—breast cancer	3.48e-07	3.22e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CB—breast cancer	3.4e-07	3.14e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTGS2—breast cancer	3.37e-07	3.11e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—breast cancer	3.32e-07	3.07e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CAV1—breast cancer	3.21e-07	2.97e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—breast cancer	3.04e-07	2.81e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—breast cancer	3.01e-07	2.78e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—breast cancer	2.94e-07	2.72e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTEN—breast cancer	2.94e-07	2.71e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CG—breast cancer	2.92e-07	2.7e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—breast cancer	2.78e-07	2.57e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CD—breast cancer	2.57e-07	2.38e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—breast cancer	2.54e-07	2.35e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—breast cancer	2.54e-07	2.35e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—breast cancer	2.46e-07	2.27e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NOS3—breast cancer	2.43e-07	2.24e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—breast cancer	2.4e-07	2.22e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—breast cancer	2.27e-07	2.1e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CB—breast cancer	2.24e-07	2.07e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTGS2—breast cancer	2.22e-07	2.05e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—breast cancer	2.08e-07	1.92e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—breast cancer	2.07e-07	1.91e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTEN—breast cancer	1.94e-07	1.79e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—breast cancer	1.69e-07	1.56e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—breast cancer	1.37e-07	1.26e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—breast cancer	1.12e-07	1.03e-06	CbGpPWpGaD
